| abstract |
The invention relates to the use of isoquinoline derivatives of general formula (I) wherein R?1, R2 and R3¿ are hydrogen, halogen, lower alkyl, lower alkoxy or R?2 and R3¿ taken together form a methylenedioxy group, Z is (a), (b), (c) or (d); R is CF¿3?, halogen, lower alkoxy, lower alkyl or lower alkyl-halogen; p is 1-3; n is 0-5 and of their pharmaceutically acceptable salts in the treatment of disorders which are associated with 5HT7 receptors. |